Monday, August 31, 2026

First Horizon National Stock Went Down By Over 32% In The Last 21 Sessions

First Horizon National Stock Went Down By Over 32% In The Last 21 Sessions

(VIANEWS) - Shares of First Horizon National (NYSE: FHN) slid by a staggering 32.03% in 21 sessions from $24.67 to $16.77 at 11:54 EST on Tuesday, after three sequential sessions in a row of losses. NYSE is rising 1.78% to $15,027.16, after two successive sessions in a row of losses.

First Horizon National's last close was $16.04, 35.63% under its 52-week high of $24.92.

About First Horizon National

First Horizon Corporation operates as the bank holding company for First Horizon Bank that provides various financial services. The company operates through three segments: Regional Banking, Specialty Banking, and Corporate. It offers general banking services for consumers, businesses, financial institutions, and governments. The company also underwrites bank-eligible securities and other fixed-income securities eligible for underwriting by financial subsidiaries; sells loans and derivatives; and offers advisory services. In addition, it offers various services, such as mortgage banking; title insurance and loan-closing; brokerage; correspondent banking; nationwide check clearing and remittance processing; trust, fiduciary, and agency; equipment finance; and investment and financial advisory services. Further, the company sells mutual fund and retail insurance products; and credit cards. It operates approximately 500 banking offices in 22 states under the First Horizon Bank brand; and 400 banking centers in 12 states under the FHN Financial brand in the United States. The company was formerly known as First Horizon National Corporation and changed its name to First Horizon Corporation in November 2020. First Horizon Corporation was founded in 1864 and is headquartered in Memphis, Tennessee.

Earnings Per Share

As for profitability, First Horizon National has a trailing twelve months EPS of $2.08.

PE Ratio

First Horizon National has a trailing twelve months price to earnings ratio of 8.05. Meaning, the purchaser of the share is investing $8.05 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.7%.

Volume

Today's last reported volume for First Horizon National is 6629281 which is 8.74% above its average volume of 6062540.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, First Horizon National's stock is considered to be overbought (>=80).

Moving Average

First Horizon National's worth is way under its 50-day moving average of $24.12 and way under its 200-day moving average of $23.46.

Volatility

First Horizon National's last week, last month's, and last quarter's current intraday variation average was a negative 7.79%, a negative 2.75%, and a positive 1.07%.

First Horizon National's highest amplitude of average volatility was 7.93% (last week), 2.93% (last month), and 1.07% (last quarter).

More news about First Horizon National (FHN).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com